ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1067

Identification of miRNAs in Systemic Sclerosis Based on Activity and Network Analysis­­­

Yiwei Yuan1, Yue Wang 2, Patricia Pioli 3 and Michael Whitfield 4, 1Geisel School of Medicine at Dartmouth, Hanover, 2Geisel School of Medicine at Dartmouth, Hanover, NH, 3Dartmouth College, Hanover, 4Geisel School of Medicine at Dartmouth College, Biomedical Data Science at Dartmouth College, Hanover

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: bioinformatics and networking, MicroRNA, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc; scleroderma) is a rare, heterogenous autoimmune disease characterized by skin fibrosis, vasculopathy and internal organ involvement. SSc patients can be divided into four intrinsic gene expression subtypes: inflammatory, fibroproliferative, limited and normal-like. The expression and activity of miRNAs, non-coding RNAs that post-transcriptionally regulate gene expression, have not been comprehensively characterized across the intrinsic gene expression subsets.  We investigated the regulation and activity of miRNAs across the SSc subsets, developed a miRNA-target network, and experimentally validated a key hub of the network.

Methods: ­­Gene expression profiles were downloaded for two patient cohorts, Milano et al. (GSE9285; 75 samples) and Assassi et al. (GSE58095; 102 samples). miRNA-target interactions (MTIs) were collected from miRTarBase; the activity of each miRNA is based on the expression of its target genes. The BASE algorithm was used to generate the miRNA regulatory activity scores for each miRNA in each sample. A Wilcoxon rank sum test was used to identify miRNAs with differential activity in inflammatory and fibroproliferative SSc samples. A miR-seq was performed on 8 SSc and 4 healthy control skin samples to validate findings. Targets strongly inhibited by cognate miRNAs were used to create the MTI network by calculating their negative correlation. The R package “igraph” was used for visualization and topological analysis of the network. Centrality measures were used to determine the node importance. For the most essential miRNAs, target genes were ranked and functionally annotated by pathway enrichment analysis using g:Profiler. miRNAs knockdowns in primary human SSc-differentiated macrophages were used to validate in-silico analyses.

Results: We identified a total of 198 miRNAs that were consistently differentially activated in both datasets (149 miRNAs were upregulated, and 49 miRNAs were downregulated). 1534 target genes were connected to these miRNAs in the network. Topological measurements of the network revealed that miR-155-5p and miR-21-5p had the broadest influence throughout the network. Both miR-155-5p and miR-21-5p showed consistently high activity in inflammatory and fibroproliferative SSc samples, and were highly expressed by miR-seq.  MiR-155-5p has 92 target genes in this network that are significantly enriched in pathways that regulate inflammation and macrophage activation including the FoxO signaling pathway, which has been shown to mediate the prevention of autoimmunity.

Conclusion: We identified a list of miRNAs ­­that show differential activity in SSc samples. MiR-155-5p and miR-21-5p were the most central in the regulatory network topologically, and have significantly higher activity and expression in inflammatory and fibroproliferative SSc samples. Over-activation of miR-155-5p leads to the loss of pathways associated with inhibition of autoimmune disease and proliferation of muscle cells.


Abstract_panel

Figure 1: The identification of miRNA in SSc based on activity and network analysis. -A- Heatmap of miRNAs with differential activity in Milano dataset. -B- Venn diagram plot of miRNAs with the consistent direction within datasets. -C- miRNA-target network using miRNAs with differntial activity and targets. -D- and -E-: Boxplot for miR-155-5p and miR-21-5p activity in Milano dataset. -F- Enriched pathways of miR-155-5p targets.


Disclosure: Y. Yuan, None; Y. Wang, None; P. Pioli, None; M. Whitfield, None.

To cite this abstract in AMA style:

Yuan Y, Wang Y, Pioli P, Whitfield M. Identification of miRNAs in Systemic Sclerosis Based on Activity and Network Analysis­­­ [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/identification-of-mirnas-in-systemic-sclerosis-based-on-activity-and-network-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-mirnas-in-systemic-sclerosis-based-on-activity-and-network-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology